CV Sciences, Inc. to Webcast Live at June 1, 2017

Company invites individual and institutional investors as well as advisors to attend interactive real-time virtual presentation at

LAS VEGAS, May 30, 2017 /CNW/ -- CV Sciences, Inc. (OTCQB: CVSI), today announced that Chief Financial Officer Joseph Dowling will present live at on June 1, 2017.

DATE: Thursday, June 1, 2017
TIME: 11:30 AM EDT

This will be a live, interactive online event where investors are invited to ask the company questions in real time - both in the presentation hall as well as the association's "virtual trade booth." If attendees are not able to join the event live on the day of the conference, an on-demand archive will be available for 90 days.

It is recommended that investors pre-register and run the online system check to save time and receive event updates.

Learn more about the event at

Recent Company Highlights

  • CV Sciences, Inc. will meet with the Food and Drug Administration (FDA) in June 2017 to discuss its initial drug candidate (CVSI-007).
  • In March 2017, CV Science, Inc. announced its first online education platform designed to enhance its brand education and advocacy through Experticity.
  • CV Sciences. Inc. appointed Dr. Stephen M. Schmitz to its board of directors to help move its drug development program forward to commercialization.

About CV Sciences, Inc.

CV Sciences, Inc. (OTCQB: CVSI) operates two distinct business segments: a drug development division focused on developing and commercializing novel therapeutics utilizing synthetic CBD; and a consumer product division focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors. CV Sciences, Inc. has primary offices and facilities in Las Vegas, Nevada and San Diego, California. Additional information is available at or

Since 2010,, created by BetterInvesting (NAIC) and PRNewswire, has been the only monthly virtual investor conference series that provides an interactive forum for presenting companies to meet directly with investors using a graphically-enhanced online platform.

Designed to replicate the look and feel of location-based investor conferences, Virtual Investor Conferences unites PR Newswire's leading-edge online conferencing and investor communications capabilities with BetterInvesting's extensive retail investor audience network.


SOURCE CV Sciences, Inc.

For further information: Robert Haag, Managing Director, 866-976-4784,; Bradley H. Smith, Director of Marketing, IR and Compliance Services, PR Newswire, +1.201.947.7157,

Organization Profile

CV Sciences, Inc.

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890